These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7954610)

  • 41. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J; Yellon DM; Baxter GF
    Br J Pharmacol; 1999 Feb; 126(3):701-8. PubMed ID: 10188982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits.
    Andreadou I; Iliodromitis EK; Souridis V; Prokovas E; Kostidis S; Zoga A; Dagres N; Tsantili-Kakoulidou A; Kremastinos DT; Mikros E; Anastasiou-Nana M
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):609-16. PubMed ID: 21822143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ischaemic preconditioning limits infarct size in the rat heart.
    Yellon DM; Alkhulaifi AM; Browne EE; Pugsley WB
    Cardiovasc Res; 1992 Oct; 26(10):983-7. PubMed ID: 1486593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of human recombinant superoxide dismutase on canine myocardial infarction.
    Patel BS; Jeroudi MO; O'Neill PG; Roberts R; Bolli R
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H369-80. PubMed ID: 2309904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits.
    Miki T; Cohen MV; Downey JM
    Basic Res Cardiol; 1999 Jun; 94(3):180-7. PubMed ID: 10424236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
    Walsh RS; Tsuchida A; Daly JJ; Thornton JD; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Sep; 28(9):1337-41. PubMed ID: 7954642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits.
    Tanaka M; Fujiwara H; Yamasaki K; Miyamae M; Yokota R; Hasegawa K; Fujiwara T; Sasayama S
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1476-82. PubMed ID: 7943394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Mar; 29(3):401-6. PubMed ID: 7781014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the preconditioning.
    Goto M; Miura T; Itoya M; Sakamoto J; Iimura O
    Basic Res Cardiol; 1993; 88(6):594-606. PubMed ID: 8147824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
    Zhao ZQ; Nakanishi K; McGee DS; Tan P; Vinten-Johansen J
    Cardiovasc Res; 1994 Feb; 28(2):270-9. PubMed ID: 8143310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.
    Suzuki K; Miura T; Miki T; Tsuchida A; Shimamoto K
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):1-9. PubMed ID: 9456270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoflurane does not mimic ischaemic preconditioning in decreasing hydroxyl radical production in the rabbit.
    Gozal Y; Raphael J; Rivo J; Berenshtein E; Chevion M; Drenger B
    Br J Anaesth; 2005 Oct; 95(4):442-7. PubMed ID: 16040636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ischaemic preconditioning by partial occlusion without intermittent reperfusion.
    Koning MM; Simonis LA; de Zeeuw S; Nieukoop S; Post S; Verdouw PD
    Cardiovasc Res; 1994 Aug; 28(8):1146-51. PubMed ID: 7954615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].
    Tamura Y; Saito S; Hatano M; Lucchesi BR
    Kokyu To Junkan; 1989 Feb; 37(2):201-8. PubMed ID: 2727408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preconditioning with supply-demand imbalance limits infarct size in dog heart.
    Iwamoto T; Bai XJ; Downey HF
    Cardiovasc Res; 1993 Nov; 27(11):2071-6. PubMed ID: 8287420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction. Polyethylene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs.
    Tanaka M; Stoler RC; FitzHarris GP; Jennings RB; Reimer KA
    Circ Res; 1990 Sep; 67(3):636-44. PubMed ID: 2397573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.